Latest filing published 06 Jan 2026 for Mersana Therapeutics, Inc..
Insider track record
No signal scores available.
Kristen Hege: trading record in brief
Kristen Hege has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Cell Genesys Inc and Mersana Therapeutics, Inc. We count 4 filings; the first trade dates from 30 July 2007 and the latest from 6 January 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 6 January 2026: a transaction, in Mersana Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kristen Hege
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 578 sharesCommon StockSEC:0001104659-26-001389:0
- 14,467 shares0Common StockSEC:0001104659-23-070363:0
- 25,000 shares0Common StockSEC:0001209191-07-045033:0
3 of 3 declarations
